- Author:
Bo Yeon KIM
1
;
Jong Chul WON
;
Jae Hyuk LEE
;
Hun Sung KIM
;
Jung Hwan PARK
;
Kyoung Hwa HA
;
Kyu Chang WON
;
Dae Jung KIM
;
Kyong Soo PARK
Author Information
- Publication Type:Original Article
- Keywords: Comorbidity; Diabetes mellitus; Hypercholesterolemia; Hypertension; Nutrition surveys; Obesity; Prevalence; Public health; Republic of Korea
- MeSH: Adult; Blood Pressure; Cholesterol, LDL; Comorbidity; Diabetes Mellitus; Fasting; Glucose; Hemoglobin A, Glycosylated; Humans; Hypercholesterolemia; Hypertension; Korea; Mortality; Nutrition Surveys; Obesity; Obesity, Abdominal; Prevalence; Public Health; Republic of Korea
- From:Diabetes & Metabolism Journal 2019;43(4):487-494
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: The objective of this study was to investigate the prevalence, management, and comorbidities of diabetes among Korean adults aged 30 years and older. METHODS: This study used 2013 to 2016 data from the Korea National Health and Nutrition Examination Survey, a nationally-representative survey of the Korean population. Diabetes was defined as fasting glucose ≥126 mg/dL, current use of antidiabetic medication, a previous history of diabetes, or glycosylated hemoglobin (HbA1c) ≥6.5%. RESULTS: In 2016, 14.4% (approximately 5.02 million) of Korean adults had diabetes. The prevalence of impaired fasting glucose was 25.3% (8.71 million). From 2013 to 2016, the awareness, control, and treatment rates for diabetes were 62.6%, 56.7%, and 25.1%, respectively. People with diabetes had the following comorbidities: obesity (50.4%), abdominal obesity (47.8%), hypertension (55.3%), and hypercholesterolemia (34.9%). The 25.1%, 68.4%, and 44.2% of people with diabetes achieved HbA1c <6.5%, blood pressure <140/85 mm Hg, and low density lipoprotein cholesterol <100 mg/dL. Only 8.4% of people with diabetes had good control of all three targets. CONCLUSION: This study confirms that diabetes is as an important public health problem. Efforts should be made to increase awareness, detection, and comprehensive management of diabetes to reduce diabetes-related morbidity and mortality.

